Rezultati pretraživanja
  1. 31. sij

    First US patient treated with . Hard to wrap your mind around the fact that your pipetting may have helped save a human life

  2. 4. velj

    Regarding the drug Remdesivir, which has not be marketed in China and has intellectual property barriers, we applied for a Chinese invention patent on January 21 (the purpose of anti-2019-nCoV) from the perspective of protecting national interests...

    Prikaži ovu nit
  3. 1. velj

    a wonder drug to the . Thank ! Thanks to the United States and the American people. Thanks to all the scientists and chemics who bring this miracle medicine to the world! A lot of lives can be saved!

  4. — The 1st US patient has been treated with , antiviral for . Patient’s clinical condition improved after treatment! Very encouraging! NEJM report:

  5. prije 14 sati

    Unbelievable.🇨🇳just violated the Phase I trade deal on no IP theft.🇺🇸must enforce🇨🇳2 honor all obligations under the agreement regardless of .🇺🇸provides life saving drug 2 Chinese victims while🇨🇳steals our IP. That's the reason Trump started

  6. 1. velj
  7. prije 24 sata

    I know some evens about CCP robbed patents like MUJI, like Jorden. Now is new medicine . I really admire this world who want to help CCP, but CCP always, alway use the ugly thought to deal with it. Please think twice, make sure you could handle that result.

  8. 2. velj

    We’ve expedited to develop appropriate laboratory testing of (瑞德西韦) against and initiate a , controlled of 270 patients expecting to begin tonight (03Feb) in while our effort continues to develop for

  9. 5. velj

    Would this be in blatant violation of intellectual property that the Phase-one trade deal should honor?

  10. 4. velj

    救命药 从美国运到中国,接收方《中国医科院病毒研究所》 美国运货单价格显示: 总价:$56405.12 总数量:2843盒 每盒单价:$19.84 每盒剂量:71000毫升 每100毫升: 2美分 中国售价: 每百毫升:35550元

    Prikaži ovu nit
  11. 1. velj

    Two interventions might beat the : vaccines and antiviral medications. , originally developed against , may work against . Trials must be done, and then cost and availability will be limiting factors, especially for poorer nations

  12. Sciences is considering repositioning NUC inhibitor as a treatment for the now sweeping across parts of . The antiviral last made headlines when Gilead tested it, with little success, as a treatment for virus.

    Prikaži ovu nit
  13. just approved one of the three drugs, Remdesivir, that have been used to treat patients who contracted . The 1st US patient has been treated with . Patient’s clinical condition improved after treatment! NEJM-

  14. 3. velj

    Multiple medical institutions are conducting for the anti-novel , Chinese health authorities said Monday Sourve via | People's Daily China

  15. 3. velj

    Update: Professor Cao Bin from China-Japan Friendship Hospital is now leading a controlled clinical trial of the drug with over 270 newly infected patients in China from Feb 3 to Apr 27 to determine whether can safely & effectively be used to treat .

  16. 3. velj

    The National Health Commission introduced: a number of medical institutions are carrying out clinical trials on the antiviral drug ; some clinical trials of Kaletra and traditional Chinese medicine treatment are in the process of collecting clinical data.

  17. prije 20 sati

    Pharmaceutical company gave (potentially can treat ) formulae to China for free due to the global health crisis - China repaid this kindness by getting a patent in their own name. PRC back at its disgraceful IP theft again.

    Prikaži ovu nit
  18. 2. velj

    drug begin clinical trials. Phase III clinical trial will run from Feb 3 to April 27. It is administered by Dr Cao Bin from Beijing hospital, the trial will be carried out . The drug , developed by

  19. prije 13 minuta

    : 1. the 'magical cure' to be put to use? 特效药来了? , developed by the U.S. company as a monophosphoramidate prodrug of code GS-441524 that targets viral RNA-dependent RNA polymerase is to be used on 761 patients in . Will this be

    Prikaži ovu nit
  20. 1. velj

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.